Which types of patients are Olaparib suitable for targeted therapy?

Olaparib is a targeted drug that is a PARP inhibitor (polyadenosine diphosphate ribose polymerase inhibitor). It inhibits the activity of PARP enzyme, prevents DNA repair, and induces the death of cancer cells. Lynparza is currently widely used to treat certain types of cancer, particularly those with specific genetic mutations.

Olaparib is mainly suitable for patients with BRCA1/2 gene mutations. Mutations in these genes are closely related to breast cancer, ovarian cancer and other types of cancer. BRCA1/2genes play an important role in DNA repair, but mutated BRCAgenes cannot effectively repair DNA damage, making tumor cells prone to genetic mutations. By blocking the repair mechanism of PARP enzyme, Lynparza further aggravates DNA damage and achieves therapeutic effect. BRCAPatients with ovarian, breast and prostate cancer who have mutated BRCA are the typical populations treated with olaparib.

Olaparib is also indicated for patients with certain non-BRCA mutations, particularly those with cancers that have DNA repair defects (such as HRD, homologous recombination deficiency). HRD is a widespread gene repair defect that may be present in many types of cancer. Lynparza has a good effect on these patients with DNA repair defects, especially in the treatment of ovarian cancer and breast cancer. HRDThe presence of HRD makes cancer cells more sensitive to DNA damage, thereby enhancing the therapeutic effect of Lynparza.

Olaparib is also used to treat advanced prostate cancer, particularly in patients with BRCA1/2 mutations or other related gene mutations. For these patients, olaparib, as a targeted therapy, can effectively delay disease progression and improve survival rates. Studies have shown that in patients with BRCA mutated prostate cancer, olaparib has a significant effect and can significantly extend progression-free survival. Lynparza provides a new treatment option for some patients with advanced prostate cancer who have failed to respond to traditional treatments.

Reference materials:https://www.lynparza.com/